ImmunoPrecise reported a GAAP EPS of -C$0.15 and revenue of C$5.3 million. This financial performance was disclosed in the company’s latest earnings release.
Date:
ImmunoPrecise reported a GAAP EPS of -C$0.15 and revenue of C$5.3 million. This financial performance was disclosed in the company’s latest earnings release.